Research Article
Predictive Value of Arterial Blood Lactic Acid Concentration on the Risk of in-Hospital All-Cause Death in Patients with Acute Heart Failure
Table 4
Association between NT-proBNP and the risk of in-hospital deaths.
| ||||||||||||||||||||||||||||||||||||
Abbreviation: NT-proBNP, N terminal pro B type natriuretic peptide; Q1, 122–3589 pg/ml; Q2, 3590–8367 pg/ml; Q3, 8368–11382 pg/ml; Q4, 11383–52201 pg/ml; , ; Model 1 was not adjusted for variables. Model 2 was adjusted for age, sex, ethnicity. Model 3 was adjusted for age, ethnicity, body mass index, weight, systolic blood pressure, the history of atrial fibrillation, liver cirrhosis, acute myocardial infarction, chronic kidney disease, respiratory failure, chronic obstructive pulmonary disease, ventricular fibrillation, diabetes mellitus, and septicaemia, anion gap, bicarbonate, blood urea nitrogen, serum calcium, serum creatinine, glucose, hematocrit, hemoglobin, platelet, red blood cells, C reactive protein, length of stay, albumin, white blood cells, lactic acid, cardiotonic drugs, nitro-glycerine drugs, furosemide drugs, infection-fighting drugs, simplified Acute Physiology Score II, and sequential organ failure assessment. |